ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
The APOS System: Effects on Gait, Mobility and QOL in Patients With Parkinson's Disease

This study is not yet open for participant recruitment.
Verified by Tel-Aviv Sourasky Medical Center, July 2007

Sponsored by: Tel-Aviv Sourasky Medical Center
Information provided by: Tel-Aviv Sourasky Medical Center
ClinicalTrials.gov Identifier: NCT00498758
  Purpose

The purpose of this study is to evaluate the benefits of a biomechanical wedge system - The APOS system, for improving the stability of gait, mobility and quality of life in Parkinson's disease patients.


Condition Intervention Phase
Idiopathic Parkinson's Disease
Device: APOS System - biomechanical wedge shoe
Phase II

Genetics Home Reference related topics:   Parkinson disease   

MedlinePlus related topics:   Parkinson's Disease   

U.S. FDA Resources

Study Type:   Interventional
Study Design:   Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment

Further study details as provided by Tel-Aviv Sourasky Medical Center:

Primary Outcome Measures:
  • gait characteristics [ Time Frame: 3 monthes ]
  • Quality of life [ Time Frame: 3 monthes ]
  • Mobility [ Time Frame: 3 monthes ]

Estimated Enrollment:   60
Study Start Date:   August 2007
Estimated Study Completion Date:   August 2008

Detailed Description:

Recently, a biomechanical wedge system was developed for gait and balance training among patients suffering from gait disorders. The APOS system (APOS Medical & Sports Technologies Ltd, Hertzeliya, Israel) applies special semispherical shoes, with individually adjusted implants, to improve age- and disease-related loss in muscle strength and neuromuscular control. The semispherical rubber devices that are placed on the soles of the shoes at the hind-foot and mid-foot can be moved medially, laterally, forwards and backwards. The system can be individually adjusted in order to optimally balance loading and re-train postural control during gait. An additional advantage of this treatment approach is the extraordinary compliance. The system is easily adjusted, maintained, and allows safe gait training.

After randomization, all subjects will be fitted with the APOS system, These shoes alter the dynamic balance during all gait cycle phases, adjusting the center of gravity and training postural control.

The precise location of the two wedges is adjusted individually by expert trainers using standardized protocols. Subjects in the intervention group will receive a proper wedge; subjects in the sham group will receive an almost flat wedge that lacks the proper biomechanical characteristics. However, both shoes and wedges will look similar. All subjects will be instructed to start gradually, with a goal of reaching 30 minutes of in-home walking while wearing the special training shoes. As an extra pre-caution, all subjects will be asked to walk with the shoes only in the presence of a caregiver, spouse or other family member during the first month. Before moving to more independent training, subjects will be checked for safety.

  Eligibility
Ages Eligible for Study:   50 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Criteria

Inclusion Criteria:

  • Idiopathic Parkinson's disease
  • Stage 2-3 Hoehn & Yahr

Exclusion Criteria:

  • Peripheral neuropathic pain
  • Dementia
  • Severe orthopaedic condition
  • c.v.a
  • Hearing or vision loss
  • Usage of walking aid
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00498758

Contacts
Contact: Talia Herman     talit@tasmc.health.gov.il    
Contact: Yael Rotem-Galili     rotem.yael@gmail.com    

Sponsors and Collaborators
Tel-Aviv Sourasky Medical Center

Investigators
Principal Investigator:     Nir Giladi, MD     Movement Disorders Unit - Tel Aviv Sourasky medical center    
  More Information

Study ID Numbers:   tasmc-07-ng-152-ctil
First Received:   July 9, 2007
Last Updated:   July 9, 2007
ClinicalTrials.gov Identifier:   NCT00498758
Health Authority:   Israel: Ethics Commission

Keywords provided by Tel-Aviv Sourasky Medical Center:
Parkinson's disease  
Gait Disturbances  
Mobility  
Quality of life  

Study placed in the following topic categories:
Ganglion Cysts
Movement Disorders
Parkinson Disease
Basal Ganglia Diseases
Quality of Life
Central Nervous System Diseases
Parkinsonian Disorders
Neurodegenerative Diseases
Brain Diseases

Additional relevant MeSH terms:
Nervous System Diseases

ClinicalTrials.gov processed this record on September 05, 2008




Links to all studies - primarily for crawlers